FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.

The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

“These promising data add to the evidence supporting GSK’s RSV vaccine and could help expand protection to more adults at ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for ...

GSK (GSK) reported its RSV vaccine Arexvy elicited a robust immune response in people aged 18 to 49 years who were at ...

Arexvy is currently approved for active immunization for the prevention of LRTD caused by RSV in individuals 60 years of age and older, and those 50 to 59 years of age who are at increased risk for ...

The CDC's vaccine policy advisors haven't budged on new RSV guidance, remaining unconvinced that younger adults at higher ...

Marinus said it will discontinue development of the drug, ganaxolone, and take further steps to reduce costs, including job ...

Secretary of State Antony J. Blinken said U.S. and Qatari negotiators would soon restart long-stalled negotiations, but that it remained unclear if Hamas was willing to engage. Sirajuddin Haqqani ...

Democratic presidential candidate Kamala Harris heads to the battleground of Georgia on Thursday for a star-studded rally featuring rock legend Bruce Springsteen, entertainer Tyler Perry and ...

Sirajuddin Haqqani has tried to remake himself from blood-soaked jihadist to pragmatic Taliban statesman. Western diplomats are shocked — and enticed. By Christina Goldbaum Ms. Letby, a ...